基本信息 产品详情 公司简介 推荐产品
网站主页 重组人蛋白CD30/TNFRSF8/CD30L RECEPTOR (C-FC) CD30蛋白
  • CD30/TNFRSF8重组蛋白,ACROBiosystems百普赛斯
  • CD30/TNFRSF8重组蛋白,ACROBiosystems百普赛斯
  • CD30/TNFRSF8重组蛋白,ACROBiosystems百普赛斯

1/3

CD30/TNFRSF8重组蛋白,ACROBiosystems百普赛斯

CD30
询价 100ug 起订
500ug 起订
1000ug 起订
北京 更新日期:2024-09-24

北京百普赛斯生物科技股份有限公司

VIP1年
联系人:姚经理
手机:18514007688 拨打
邮箱:jiaxin.zhao@acrobiosystems.com

产品详情:

中文名称:
CD30蛋白
英文名称:
CD30
品牌:
百普赛斯
产地:
北京
保存条件:
-20°C to -70°C
纯度规格:
99.9%
产品类别:
重组蛋白
货号:
CD30
用途范围:
药物开发等
规格:
ug
是否进口:

1.jpg

CD30产品信息

英文名称Tumor necrosis factor receptor superfamily member 8

中文名称:肿瘤坏死因子受体超家族成员8

靶点别称CD30,TNFRSF8

物种:Human

属性:Protein / Kits

标记:Biotin-labeled / FITC Labeled / Unconjugated / PE Labeled

内毒素(Endotoxin

Less than 1.0 EU per μg by the LAL method.

纯度(Purity

>90% as determined by SDS-PAGE.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

重构方法(Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 12 months in lyophilized state;

2. -70°C for 3 months under sterile conditions after reconstitution.

2.jpg

CD30分子背景

Human CD30 is also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. TNFRSF-8 is expressed by activated, but not by resting, T and B cells. Also, CD30 is expressed on classical Hodgkin Lymphoma cells together with CD15. CD30 is the receptor for TNFSF8/CD30L. CD30 can interact with TRAF2 and TRAF5, and mediate the signal transduction that leads to the activation of NF-kappa-B. TNFRSF8 may play a role in the regulation of cellular growth and transformation of activated lymphoblasts. TNFRSF8 is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity.

CD30用户评价

3.jpg

CD30;CD30蛋白;TNFRSF8;TNFRSF8蛋白;CD30重组蛋白;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。

成立日期 (15年)
注册资本 8000万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药

CD30蛋白相关厂家报价

内容声明
拨打电话 立即询价